Owkin
Alex Cornish is a seasoned computational biologist currently serving as a Senior Computational Biologist at Owkin, focusing on data processing and analysis from the MOSAIC spatial multi-omics dataset in oncology and employing AI for drug development initiatives. Prior experience includes a role as a Senior Bioinformatics Data Scientist at BenevolentAI, where collaboration with AstraZeneca facilitated drug target identification for heart failure and systemic lupus erythematosus, alongside mentoring responsibilities. Cornish also contributed to cancer genomics as a Postdoctoral Researcher at The Institute of Cancer Research, analyzing whole-genome sequencing data from Genomics England's 100,000 Genomes Project. Academic qualifications include a Ph.D. in Bioinformatics from Imperial College London, an MPhil in Computational Biology from the University of Cambridge, and a BSc in Natural Sciences from Durham University.
This person is not in any teams
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.